Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.6800
+0.1100 (7.01%)
NASDAQ· Last Trade: May 20th, 6:07 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors